The Human Uterus Cell Atlas (HUTER) project aims to create the single-cell and spatial reference map of the human uterus. HUTER project will provide unprecedented insight at transcriptomic, genomic and spatial changes of this important female organ not only throughout the menstrual cycle but also across lifespan. The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women´s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynaecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine. The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women´s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity. HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.

BodyPass aims to break barriers between health sector and consumer goods sector and eliminate the current data silos. The main objective of BodyPass is to foster exchange, linking and re-use, as well as to integrate 3D data assets from the two sectors. For this, BodyPass has to adapt and create tools that allow a secure exchange of information between data owners, companies and subjects (patients and customers). 3D personal data is type of data that contains useful information for product design, online sale services, medical research and patient follow-up. Currently hospitals store and grow massive collections of 3D data that are not accessible by researchers, professionals and companies. About 2.7 petabytes a year stored in the EU26. In parallel to the advances made in the health sector, new 3D body-surface scanning technology has been developed for the goods consumer sector, namely apparel, animation and art. Moreover, new low-cost scanning technologies are expected to exponentially increase 3D data creation. It is estimated that currently one person is scanned every 15 minutes in the US and Europe. And increasing. The 3D data of the health sector contains the body shape information, not only internal body information. These data could be used by designers and manufacturers of the consumer goods sector. At the same time, although 3D body-surface scanners have been developed primarily for the clothing industry, 3D scanners’ low cost, non-invasive character, and ease of use make them appealing for widespread clinical applications and large-scale epidemiological surveys. However, companies and professionals of the consumer goods sector cannot access the 3D data of health sector. And vice versa. Even exchanging information between data owners in the same sector is a big problem today. It is necessary to overcome problems related with data privacy and the processing of huge 3D datasets.

Pathology has repeatedly been highlighted as being ripe for innovation in terms of workflow efficiency and more accurate diagnostics. In fact, the estimated market growth for digital pathology systems is huge, with the forecast to reach 143 million dollars by 2019 in the EU and 205 million dollars in the USA. Despite this boost in sales, diagnostic pathology in practice today is still a slow and cumbersome process that relies heavily on the subjective interpretation of a microscopic image by a qualified pathologist. This imposes a limitation, even more substantial in small pathology departments where the pathologists might not be specialized in particular areas. CLARIFY addresses the challenge to improve pathology departments’ workflow optimising current diagnosis and monitoring processes. With this purpose, CLARIFY’s scientific goal is to develop a robust automated digital diagnostic environment based on cutting-edge technologies (such as digital image processing, artificial intelligence, cloud computing, blockchain, etc.) to enhance knowledge sharing and reach better‐informed decisions. To achieve it, CLARIFY targets to deliver an innovative, multinational, multi-sectorial, and multidisciplinary research and training programme that link two highly differentiated specialities: engineering and medicine, with a focus on digital pathology. CLARIFY’s partnership gathers relevant scientific staff from academia, industry and hospitals, which will be involved in a high-level personalised training programme that will guarantee ESRs and future PhD students outstanding Career Opportunities. CLARIFY will disseminate results to a wide spectrum of stakeholders, create awareness in the general public about digital pathology and encourage careers related to this field among young students.

More than 500 million people on three continents are united by the world's largest sea, the Mediterranean. Our strategic geographic location and the shared history gives us a common character and common challenges. Mediterranean Researchers' Night - MEDNIGHT objective is to generate a Mediterranean unity, providing awareness about common problems, fostering scientific careers, reinforcing researchers’ commitment and progress, and putting science and scientists at the cornerstone of our future and a relevant matter. MEDNIGHT shows the attractiveness and importance of the researchers’ work and professions to the general public, and specially for girls and boys, carrying out a series of activities framed under the common umbrella of what we have come to call “Mediterranean Science” placing particular emphasis on youngsters and female researchers and showing the potential of R&D as a source of progress and well-being. Mediterranean Science relates to research developed in the our territories but also the countless collaborations with other EU researchers. Mediterranean Science is focused on Mediterranean relevant topics according to our culture, way of life or current challenges: Sea and pollution, Climate and clean energies, Diet and nutrition, life and Health. Many online and face-to-face diverse activities are organised by MEDNIGHT consortium in Valencia, San Juan, Orihuela, Torrevieja, Messina, Lesvos, Nicosia, Istanbul (Main cities), and also Lliria, Santa Pola, Limnos, Rhodes, Syros Eyupsultan, Kadikov, or El Cairo, among others (Satellite cities).